Interim Results from a Multicenter Observational Safety Study of Patients Treated with Voretigene Neparvovec-Rzyl in the United States

Aaron Nagiel, Stephen R. Russell, Byron L. Lam, Jason I. Comander, Tomas S. Aleman, Cagri G. Besirli, Robert A. Sisk, Paul Yang, Christina Y. Weng, Daniel C. Chung, Aishwarya Thakre, Juha-Matti Savola, David L. Rousso, Christina Weng, Tim Stout, Tahira Scholle, Aaron Nagiel, Mark Borchert, Hillary Schwartz, Thomas Lee, Robert Sisk, Christopher Riemann, Jason Comander, Paul Yang, Steven Bailey, Lesley Everett, Andreas Lauer, Mark Pennesi, Tomas S. Aleman, Albert M. Maguire, Stephen Russell, Arlene Drack, Alina Dumitrescu, Ian Han, Scott Larson, Elliott Sohn, Byron Lam, Audina Berrocal, Janet Davis, Ninel Gregori, Carlos Mendoza-Santiesteban, Justin Townsend, Cagri Besirli, Kari Branham, Abigail Fahim, Kanishka Jayasundera, Naheed Khan

Open source

DOI: 10.1016/j.ophtha.2026.07.007
Published: 2026-07
Container: Ophthalmology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ophtha.2026.07.007,
  title = {Interim Results from a Multicenter Observational Safety Study of Patients Treated with Voretigene Neparvovec-Rzyl in the United States},
  author = {Aaron Nagiel and Stephen R. Russell and Byron L. Lam and Jason I. Comander and Tomas S. Aleman and Cagri G. Besirli and Robert A. Sisk and Paul Yang and Christina Y. Weng and Daniel C. Chung and Aishwarya Thakre and Juha-Matti Savola and David L. Rousso and Christina Weng and Tim Stout and Tahira Scholle and Aaron Nagiel and Mark Borchert and Hillary Schwartz and Thomas Lee and Robert Sisk and Christopher Riemann and Jason Comander and Paul Yang and Steven Bailey and Lesley Everett and Andreas Lauer and Mark Pennesi and Tomas S. Aleman and Albert M. Maguire and Stephen Russell and Arlene Drack and Alina Dumitrescu and Ian Han and Scott Larson and Elliott Sohn and Byron Lam and Audina Berrocal and Janet Davis and Ninel Gregori and Carlos Mendoza-Santiesteban and Justin Townsend and Cagri Besirli and Kari Branham and Abigail Fahim and Kanishka Jayasundera and Naheed Khan},
  year = {2026},
  journal = {Ophthalmology},
  doi = {10.1016/j.ophtha.2026.07.007},
  url = {https://doi.org/10.1016/j.ophtha.2026.07.007}
}

RIS

TY  - JOUR
TI  - Interim Results from a Multicenter Observational Safety Study of Patients Treated with Voretigene Neparvovec-Rzyl in the United States
AU  - Aaron Nagiel
AU  - Stephen R. Russell
AU  - Byron L. Lam
AU  - Jason I. Comander
AU  - Tomas S. Aleman
AU  - Cagri G. Besirli
AU  - Robert A. Sisk
AU  - Paul Yang
AU  - Christina Y. Weng
AU  - Daniel C. Chung
AU  - Aishwarya Thakre
AU  - Juha-Matti Savola
AU  - David L. Rousso
AU  - Christina Weng
AU  - Tim Stout
AU  - Tahira Scholle
AU  - Aaron Nagiel
AU  - Mark Borchert
AU  - Hillary Schwartz
AU  - Thomas Lee
AU  - Robert Sisk
AU  - Christopher Riemann
AU  - Jason Comander
AU  - Paul Yang
AU  - Steven Bailey
AU  - Lesley Everett
AU  - Andreas Lauer
AU  - Mark Pennesi
AU  - Tomas S. Aleman
AU  - Albert M. Maguire
AU  - Stephen Russell
AU  - Arlene Drack
AU  - Alina Dumitrescu
AU  - Ian Han
AU  - Scott Larson
AU  - Elliott Sohn
AU  - Byron Lam
AU  - Audina Berrocal
AU  - Janet Davis
AU  - Ninel Gregori
AU  - Carlos Mendoza-Santiesteban
AU  - Justin Townsend
AU  - Cagri Besirli
AU  - Kari Branham
AU  - Abigail Fahim
AU  - Kanishka Jayasundera
AU  - Naheed Khan
PY  - 2026
JO  - Ophthalmology
DO  - 10.1016/j.ophtha.2026.07.007
UR  - https://doi.org/10.1016/j.ophtha.2026.07.007
ER  -

APA

Nagiel, A., Russell, S. R., Lam, B. L., Comander, J. I., Aleman, T. S., Besirli, C. G., Sisk, R. A., Yang, P., Weng, C. Y., Chung, D. C., Thakre, A., Savola, J., Rousso, D. L., Weng, C., Stout, T., Scholle, T., Nagiel, A., Borchert, M., Schwartz, H., Lee, T., Sisk, R., Riemann, C., Comander, J., Yang, P., Bailey, S., Everett, L., Lauer, A., Pennesi, M., Aleman, T. S., Maguire, A. M., Russell, S., Drack, A., Dumitrescu, A., Han, I., Larson, S., Sohn, E., Lam, B., Berrocal, A., Davis, J., Gregori, N., Mendoza-Santiesteban, C., Townsend, J., Besirli, C., Branham, K., Fahim, A., Jayasundera, K., & Khan, N. (2026). Interim Results from a Multicenter Observational Safety Study of Patients Treated with Voretigene Neparvovec-Rzyl in the United States. Ophthalmology. https://doi.org/10.1016/j.ophtha.2026.07.007

Source records

crossref · retrieved 2026-09-27T07:03:14.228Z